{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T19:57:24.390745+00:00","published_at":"2026-10-16T13:51:46.791311+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:hykq38ja9wo4","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:carole-huntsman","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:5491a42f53b0671c41b2f81865ac13ee09dafcdf0befe983a54b80b713ed6ef8"],"summary":"Carole Huntsman executive of MADRIGAL PHARMACEUTICALS, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2p0vxx9uuh1r","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:david-soergel-m-d","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:04e24728e88c1b8a00af337f57cf0789cf30dbfa6d8410a1cbbf79b90cec664c"],"summary":"David Soergel, M.D. executive of MADRIGAL PHARMACEUTICALS, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hmr845c3llnn","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:shannon-kelley","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:21"],"evidence_ids":["alpha:projection-evidence:document:9a8eddf995c3be4159b41d68fc3d88c7589b33a53fc6e871458fea98bb68dbbf"],"summary":"Shannon Kelley executive of MADRIGAL PHARMACEUTICALS, INC., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ud8m2j1ga0y0n","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:jacqualyn-a-fouse-phd","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Jacqualyn A. Fouse, Ph.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1suyw6b1icskr3","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:committee:madrigal-pharmaceuticals-inc:audit-nominating-and-governance","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Audit; Nominating and Governance committee of MADRIGAL PHARMACEUTICALS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uwazus5gemsa","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:jacqualyn-a-fouse-phd","alpha:committee:madrigal-pharmaceuticals-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Jacqualyn A. Fouse, Ph.D. member of Audit; Nominating and Governance, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:rbgdcfgpuean","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:bill-sibold-2","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Bill Sibold seat on MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jq35yc9gtwz4","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:julian-c-baker","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Julian C. Baker seat on MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8ubd0b5q12ir","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:raymond-cheong-ph-d-m-d","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Raymond Cheong, Ph.D., M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ndmawkyy6tjc","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:committee:madrigal-pharmaceuticals-inc:nominating-and-governance-chair","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Nominating and Governance · Chair committee of MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8g36xl1yhp77p","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:julian-c-baker","alpha:committee:madrigal-pharmaceuticals-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Julian C. Baker member of Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ubmner19ow9k5","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:james-m-daly","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"James M. Daly seat on MADRIGAL PHARMACEUTICALS, INC., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1obdbyea8dbi4","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:james-m-daly","alpha:committee:madrigal-pharmaceuticals-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"James M. Daly member of Audit; Nominating and Governance, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wp0sgavqtk64","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:fred-b-craves-ph-d","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Fred B. Craves, Ph.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yzeds71m7bgnz","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:kenneth-m-bate","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Kenneth M. Bate seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:lfdrzk115bdos","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:paul-a-friedman-m-d","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Paul A. Friedman, M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ovtxa41qvimgu","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:rebecca-taub-m-d","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Rebecca Taub, M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wjhot3zxxb6r","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:richard-s-levy-m-d","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Richard S. Levy, M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fbenv3wxsbi7","event_type":"COMMITTEE_CREATED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:committee:madrigal-pharmaceuticals-inc:audit-chair-compensation","alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Audit · Chair; Compensation committee of MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8n30zv1uz1zs9","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:51:46.791311+00:00","subject_ids":["alpha:person:kenneth-m-bate","alpha:committee:madrigal-pharmaceuticals-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d"],"summary":"Kenneth M. Bate member of Audit · Chair; Compensation, effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:6","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bill-sibold-2","object_label":"Bill Sibold","object_source_name_forms":[],"value":"Bill Sibold: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bill-sibold-2","name":"Bill Sibold"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:7","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:fred-b-craves-ph-d","object_label":"Fred B. Craves, Ph.D.","object_source_name_forms":[],"value":"Fred B. Craves, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:fred-b-craves-ph-d","name":"Fred B. Craves, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:8","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jacqualyn-a-fouse-phd","object_label":"Jacqualyn A. Fouse, Ph.D.","object_source_name_forms":[],"value":"Jacqualyn A. Fouse, Ph.D.: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:9","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-m-daly","object_label":"James M. Daly","object_source_name_forms":[],"value":"James M. Daly: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-m-daly","name":"James M. Daly"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:10","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:julian-c-baker","object_label":"Julian C. Baker","object_source_name_forms":[],"value":"Julian C. Baker: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:11","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kenneth-m-bate","object_label":"Kenneth M. Bate","object_source_name_forms":[],"value":"Kenneth M. Bate: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kenneth-m-bate","name":"Kenneth M. Bate"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:12","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-a-friedman-m-d","object_label":"Paul A. Friedman, M.D.","object_source_name_forms":[],"value":"Paul A. Friedman, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-a-friedman-m-d","name":"Paul A. Friedman, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:13","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-cheong-ph-d-m-d","object_label":"Raymond Cheong, Ph.D., M.D.","object_source_name_forms":[],"value":"Raymond Cheong, Ph.D., M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:raymond-cheong-ph-d-m-d","name":"Raymond Cheong, Ph.D., M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:14","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rebecca-taub-m-d","object_label":"Rebecca Taub, M.D.","object_source_name_forms":[],"value":"Rebecca Taub, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rebecca-taub-m-d","name":"Rebecca Taub, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:15","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-s-levy-m-d","object_label":"Richard S. Levy, M.D.","object_source_name_forms":[],"value":"Richard S. Levy, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-s-levy-m-d","name":"Richard S. Levy, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:17","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:carole-huntsman","object_label":"Carole Huntsman","object_source_name_forms":[],"value":"Carole Huntsman: Executive Vice President and Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:carole-huntsman","name":"Carole Huntsman"},"title":"Executive Vice President and Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:5491a42f53b0671c41b2f81865ac13ee09dafcdf0befe983a54b80b713ed6ef8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MDGL DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T12:22:14.184606+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:19","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-soergel-m-d","object_label":"David Soergel, M.D.","object_source_name_forms":[],"value":"David Soergel, M.D.: Executive Vice President and Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-soergel-m-d","name":"David Soergel, M.D."},"title":"Executive Vice President and Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:04e24728e88c1b8a00af337f57cf0789cf30dbfa6d8410a1cbbf79b90cec664c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MDGL DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T12:22:15.328745+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:21","subject_id":"alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:shannon-kelley","object_label":"Shannon Kelley","object_source_name_forms":[],"value":"Shannon Kelley: Executive Vice President and Chief Legal Counsel","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:shannon-kelley","name":"Shannon Kelley"},"title":"Executive Vice President and Chief Legal Counsel","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:51:46.791311+00:00","sources":[{"id":"alpha:projection-evidence:document:9a8eddf995c3be4159b41d68fc3d88c7589b33a53fc6e871458fea98bb68dbbf","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MDGL DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T12:22:14.769023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Madrigal Pharmaceuticals DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-05-01T01:05:03.483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5491a42f53b0671c41b2f81865ac13ee09dafcdf0befe983a54b80b713ed6ef8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MDGL DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T12:22:14.184606+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:04e24728e88c1b8a00af337f57cf0789cf30dbfa6d8410a1cbbf79b90cec664c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MDGL DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T12:22:15.328745+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9a8eddf995c3be4159b41d68fc3d88c7589b33a53fc6e871458fea98bb68dbbf","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MDGL DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T12:22:14.769023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.822,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.798,"cross_source_agreement":0.75,"temporal_completeness":0.542},"diagnostics":{"published_claims":32,"factual_claims":32,"claims_with_linked_evidence":32,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":24,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:51:46.791311+00:00","observed_at":"2026-10-16T13:51:46.791311+00:00","reviewed_at":"2026-10-16T13:51:46.791311+00:00","verified_at":"2026-10-16T13:51:46.791311+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":32,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/madrigal-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}